Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel anti-BMP6 targeted antibody reduces the need for EPO in anemia of chronic disease models

Dec. 21, 2018

Selatogrel significantly inhibits platelet aggregation in phase II studies

Dec. 19, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

FLT180a gene therapy safe in first two hemophilia B patients in clinical trial

Dec. 5, 2018

University of Pennsylvania divulges anti-PF-4 antibodies

Dec. 5, 2018

ASH 2018: Multiple studies give new insights into clotting cascade

Dec. 4, 2018

Bayer presents first phase I data for BAY-1093884 in patients with hemophilia

Dec. 3, 2018

Bayer initiates phase I II study of factor VIII gene transfer therapy with BAY-2599023

Dec. 3, 2018

Jivi approved in Europe for hemophilia A

Nov. 29, 2018

Preclinical evaluation of zifaxaban, an oral inhibitor of factor Xa for thromboembolic diseases

Nov. 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...